Skip to main content

CymaBay Therapeutics, Inc.

CBAYDelisted Mar 22, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001042074

CymaBay Therapeutics, Inc. was delisted on Mar 22, 2024; its insiders filed their last Form 4 on Mar 22, 2024; 200 institutions reported holding it in 13F filings for Q4 2023, worth $2.71B in total; no superinvestor held it.

Q3 2022 vs. Q2 2022

How the institutions holding CymaBay Therapeutics, Inc. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of CBAY: Q2 2022 compared with Q3 2022
MeasureQ2 2022Q3 2022Change
Holders106100−6
Shares63.0M62.3M−746.8K (−1.2%)
Value$185.9M$217.9M+$32.0M (+17.2%)

New holders (12)

Institutions that held CymaBay Therapeutics, Inc. at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to CBAY in Q3 2022
InstitutionSharesValue% of portfolio
Great Point Partners LLC799,439$2.80M0.67%
Healthcare of Ontario Pension Plan Trust Fund596,300$2.09M0.01%
EAM Investors, LLC339,778$1.19M0.26%
Walleye Capital LLC219,991$770.0K0.02%
Lion Point Capital, LP219,425$704.0K0.28%
Susquehanna International Group, LLP111,284$389.0K0.00%
Walleye Trading LLC26,600$93.0K0.00%
Strategic Blueprint, LLC18,200$64.0K0.01%
Squarepoint Ops LLC17,495$61.0K0.00%
Dynamic Technology Lab Private Ltd10,094$35.0K0.00%
China Universal Asset Management Co., Ltd.793$3.00K0.00%
Macroview Investment Management LLC1$00.00%

Sold out (18)

Institutions that held CymaBay Therapeutics, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.